28 juin 2024 – ENANTIOS, an ETH Zurich deep-tech Spin-off, has announced the completion of its seed financing round. The ENANTIOS technology, developed over a five year research project at ETH Zurich, enables the complete characterization of complex molecules and aspects of the three dimensional structure which are not possible to resolve with other methods. The new funds shall be used in particular for technology development and enhancement, talent acquisition and strategic partnership to accelerate its go-to-market. Privilège Ventures led this funding round with additional capital from Zürcher Kantonalbank and several Family Offices and private investors.

Walder Wyss has advised ENANTIOS on this transaction. The team included Alex Nikitine (Partner, Corporate/M&A), Letizia Schlegel (Associate, Corporate/M&A), Stefan Walder (Counsel, Corporate/M&A) and Fabienne Limacher (Partner, Tax).